So in terms of what Canada can do, you talked about that, and one thing that we know from previous testimony, Mr. Attaran's testimony today, is that other countries are producing those drugs and making them available much more cheaply than Canada can.
What we do know is working is the funding of the global fund now. The government just announced a third replenishment of $540 million from 2011 to 2013. That's a 20% increase from the last replenishment here in Canada, and I think $1.5 billion since its inception in 2002--very, very significant.
Speaking to what Canada can do to have a significant impact, not so concerned with where the drugs are coming from or whether they're coming through CAMR or through some other mechanism, I would think that we can agree that the most important aspect of this is that drugs are actually being received by the people who need them, to the tune of over ten times as many as were being treated in 2003.